Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment-Reference-Cited by-同舟云学术

Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment

Published:2020-01-28 Issue:3 Volume:99 Page:557-570
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Min Gi-June,Jeon Young-Woo,Park Sung-Soo,Shin Seung-Hawn,Yahng Seung-Ah,Yoon Jae-Ho,Lee Sung-Eun,Cho Byung-Sik,Eom Ki-Seong,Kim Yoo-Jin,Lee Seok,Kim Hee-Je,Min Chang-Ki,Kim Dong-Wook,Lee Jong-Wook,Cho Seok-Goo^ORCID

Funder

Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea

Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-020-03929-3.pdf

Reference21 articles.

1. Campbell J, Seymour JF, Matthews J, Wolf M, Stone J, Juneja S (2006) The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. Eur J Haematol 76:473–480. https://doi.org/10.1111/j.1600-0609.2006.00644.x

2. Morra E, Lazzarino M, Castello A, Inverardi D, Coci A, Pagnucco G, Orlandi E, Merante S, Magrini U, Zei G, Bernasconi C (1989) Bone marrow and blood involvement by non-Hodgkin's lymphoma: a study of clinicopathologic correlations and prognostic significance in relationship to the working formulation. Eur J Haematol 42:445–453. https://doi.org/10.1111/j.1600-0609.1989.tb01469.x